Stocksigma LogoStocksigma Logo

Strides Pharma Receives USFDA Form 483 With Three Observations for Alathur Facility

The USFDA concluded a routine cGMP inspection at Strides Pharma Science's formulations facility in Alathur, Chennai, conducted from 2nd Sep'26 to 11th

Strides Pharma Receives USFDA Form 483 With Three Observations for Alathur Facility

Strides Pharma Science Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 3:17 am

Strides Pharma Receives USFDA Form 483 With Three Observations for Alathur Facility The USFDA concluded a routine cGMP inspection at Strides Pharma Science's formulations facility in Alathur, Chennai, conducted from 2nd Sep'26 to 11th Sep'26. Upon completion of the inspection, the regulator issued a Form 483 containing three observations. The company confirmed it will submit its response to the USFDA within the stipulated timeframe.

Original exchange filing (PDF)

More announcements from Strides Pharma Science Ltd

All Strides Pharma Science Ltd announcements